Use of laser technologies in surgical treatment of benign prostate hyperplasia

2021 ◽  
pp. 36-45
Author(s):  
Mark Albertovich Volodin ◽  
Evgeny Nikolaevich Bolgov ◽  
Maya A. Kuzmina ◽  
Darya Dmitrievna Vasina
Keyword(s):  
Surgical Treatment ◽  
Benign Prostatic Hyperplasia ◽  
Prostatic Hyperplasia ◽  
Surgical Instruments ◽  
Prostate Hyperplasia ◽  
Minimum Diameter ◽  
Surgical Interventions ◽  
Laser Technologies ◽  
Laser Devices ◽  
Benign Prostate

The use of laser technology in the surgical treatment of patients with benign prostatic hyperplasia has recently become widespread and introduced into practice. This area of surgery uses a large range of laser modifications and methods of their application when performing surgical interventions on the prostate. The article discusses laser devices for minimally invasive operations on patients with benign prostatic hyperplasia in comparison with traditional methods of BPH surgical treatment. The advantages of using laser technologies include the reduction of the time of surgical intervention, the decrease in the number of traumatic complications and bleeding, the absence of the damaging effect of the shock wave, the possibility of using it with surgical instruments of the minimum diameter, and the possibility of using it with flexible surgical instruments.

LASER TECHNOLOGIES IN SURGERY BENEFICIAL PROSTATE HYPERPLASIA

2021 ◽  
pp. 144-153
Author(s):  
Rakhimov S.A. ◽  
Feofilov I.V. ◽  
Arbuzov I.A.
Keyword(s):  
Surgical Treatment ◽  
Benign Prostatic Hyperplasia ◽  
Transurethral Resection ◽  
Prostate Gland ◽  
Prostatic Hyperplasia ◽  
Prostate Hyperplasia ◽  
Advantages And Disadvantages ◽  
Laser Technologies ◽  
Surgical Methods ◽  
Laser Systems

Benign prostatic hyperplasia is one of the most common diseases in urological practice. The classical method of surgical treatment of benign prostatic hyperplasia is transurethral resection of the prostate gland. However, this operation is accompanied by a fairly large number of postoperative complications and is not recommended for patients with a large prostate volume, with a high cardiovascular risk, and receiving anticoagulant therapy. In recent years, the medical community has been paying close attention to laser technologies. The article provides an overview of the literature on laser methods for the treatment of benign prostatic hyperplasia. Modern laser systems are considered: holmium, thulium, diode, «green» lasers. The advantages and disadvantages of each technique are described. The results of studies of the efficacy and safety of laser surgical methods for the treatment of benign prostatic hyperplasia and their influence on the indicators of urodynamics, symptoms of the disease, and the quality of life of patients are presented. Based on the analysis of scientific literature sources, it was concluded that laser methods of surgical treatment of benign prostatic hyperplasia are clinically effective and safe. Compared with transurethral resection of the prostate, laser technologies can shorten the period of hospitalization and catheterization of patients, have a low number of complications, provide good hemostasis, and can be used regardless of the volume of the gland in patients with concomitant diseases who are taking anticoagulants. Laser methods of surgical treatment of benign prostatic hyperplasia are currently a full-fledged worthy alternative to transurethral resection of the prostate gland. Among the disadvantages of using laser systems are the duration of the operation and the need to train specialists in the technique of surgical intervention.

scholarly journals Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study

2019 ◽  
Vol 6 (1) ◽  
Author(s):  
Lan Wu ◽  
Bing-Hui Li ◽  
Yun-Yun Wang ◽  
Chao-Yang Wang ◽  
Hao Zi ◽  
...  
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Periodontal Disease ◽  
Subgroup Analysis ◽  
Benign Prostate Hyperplasia ◽  
Prostate Volume ◽  
Prostatic Hyperplasia ◽  
Health Examination ◽  
Control Analysis ◽  
Prostate Hyperplasia ◽  
Benign Prostate

Abstract Background Both periodontal disease and benign prostatic hyperplasia are age-related diseases that affect millions of people worldwide. Hence, this study aimed to investigate the association between periodontal disease and the risk of benign prostatic hyperplasia. Methods A total of 4930 participants were selected from an available health examination that was carried out in 2017, only males were considered for further analysis. All eligible males were divided into benign prostatic hyperplasia and normal groups, the benign prostatic hyperplasia group was then divided into prostate volume ≤ 60 g and > 60 g subgroups; all their periodontal status was extracted and then into normal (CPI score of 0), periodontal disease (CPI score between 1 and 4), and periodontitis (CPI score between 3 and 4) groups. The correlation between periodontal disease and benign prostatic hyperplasia was investigated using logistic regression analyses and greedy matching case-control analysis. Subgroup analysis based on prostate volume was also performed. All analyses were conducted with SAS 9.4 software. Results A total of 2171 males were selected for this analysis. The presence of periodontal disease significantly increased the risk of benign prostatic hyperplasia by 1.68 times (OR = 1.68, 95% CI: 1.26–2.24), and individuals with periodontitis showed a higher risk (OR = 4.18, 95% CI: 2.75–6.35). In addition, among matched cases and controls, this association remained robust (periodontal disease: OR = 1.85, 95% CI: 1.30–2.64; periodontitis: OR = 4.83, 95% CI: 2.57–9.07). Subgroup analysis revealed that periodontal disease significantly increased benign prostate hyperplasia risk as well (for prostate volume ≤ 60 g: OR = 1.64, 95% CI: 1.22–2.20; for volume > 60 g: OR = 2.17, 95% CI: 1.04–4.53), and there was a higher risk in the group with a prostate volume greater than 60 g. Conclusion Periodontal disease is significantly and positively associated with an increased risk of benign prostatic hyperplasia. Further validation studies should be performed to explore the relationship between periodontal treatment and benign prostate hyperplasia.

scholarly journals STRUCTURE OF PROVISION OF URGENT AND PLANNED SURGICAL CARE TO PATIENTS WITH BENIGN PROSTATE HYPERPLASIA IN RYAZAN RE-GION

2020 ◽  
Vol 8 (4) ◽  
pp. 495-501
Author(s):  
I.S. Sobennikov ◽  
◽  
V.B. Filimonov ◽  
R.V. Vasin ◽  
◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Benign Prostate Hyperplasia ◽  
Clinical Symptoms ◽  
Statistical Processing ◽  
Surgical Care ◽  
Urgent Care ◽  
Transurethral Resection Of Prostate ◽  
Prostate Hyperplasia ◽  
Surgical Interventions ◽  
Benign Prostate

Aim. To study the status of provision of planned and urgent care to patients with benign prostate hyperplasia (BPH) in round-the-clock urological hospitals of the Ryazan region in recent 5 years. Materials and Methods. Statistical processing of the data for 2015-2020 obtained from medical statistics services of urological hospitals of Ryazan was performed. The following parameters were studied: the average age of patients who turned to emergency room with the diagnosis of acute retention of urine; the amount of surgical interventions (cystectomies) per months and years of the reporting period: open adenomectomy (in the following modifications: transvesical ade-nomectomy, retropubic adenomectomy), transurethral resection of prostate. Results. A high amount of referral of patients with BPH with clinical symptoms of acute reten-tion of urine was identified. The quantity and the share of palliative surgeries in the structure of patients with BPH stays at a high level. A tendency to growth in the amount of minimally inva-sive operations in surgical treatment for BPH is noted. Conclusion. The analysis of statistical data indicates the need for improvement of the quality of dispensary observation of patients with BPH, and improvement of methods of minimally inva-sive surgical treatment of BPH.

Treatment of beneficial prostate hyperplasia of large sizes: traditional surgical, low-invasive and laser technologies (literature review)

2021 ◽  
Vol 24 (4) ◽  
pp. 62-68
Author(s):  
G. E. Roitberg ◽  
V. V. Astashov ◽  
K. G. Mkrtchyan ◽  
A. A. Lomshakov
Keyword(s):  
Urinary Tract ◽  
Surgical Treatment ◽  
Benign Prostatic Hyperplasia ◽  
Lower Urinary Tract ◽  
Clinical Symptoms ◽  
Prostate Gland ◽  
Prostatic Hyperplasia ◽  
Prostate Hyperplasia ◽  
Surgical Tactics ◽  
Lower Urinary

Benign prostatic hyperplasia – one of the most common diseases in older men. The treatment strategy for benign prostatic hyperplasia consists in its drug therapy, or active surgical tactics. The indication for planned surgical treatment of benign prostatic hyperplasia is the progression of symptoms of the lower urinary tract, which are not amenable to drug correction. Men with a large prostate volume of more than 80 m3, with severe symptoms of the lower urinary tract, with a history of acute urinary retention episodes, represent a difficult group of patients in terms of choosing the tactics of surgical treatment. This article discusses the most common operations that are used in the treatment of benign prostatic hyperplasia (especially of large sizes): open adenectomy, transurethral resection of the prostate gland, enucleation of benign prostatic hyperplasia using a holmium laser, embolization of an artery of the prostate gland. Surgical treatment of benign prostatic hyperplasia requires an individual approach to the patient, taking into account his age, concomitant pathology and clinical symptoms.

Antrodan, A β-glucan obtained from Antrodia cinnamomea mycelia, is beneficial to benign prostate hyperplasia

2015 ◽  
Vol 6 (2) ◽  
pp. 635-645 ◽  
Author(s):  
Chiung-Chi Peng ◽  
Yi-Ting Lin ◽  
Kuan-Chou Chen ◽  
Charng-Cherng Chyau ◽  
Robert Y. Peng
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Benign Prostate Hyperplasia ◽  
Prostatic Hyperplasia ◽  
Common Disease ◽  
Prostate Hyperplasia ◽  
Antrodia Cinnamomea ◽  
Benign Prostate

Benign prostatic hyperplasia (BPH), one of the most common disease usually occurring in men in their 50s, has now become an atypical direct cause of mortality.

Evaluating how much dutasteride actually reduces serum dihydrotestosterone level: A Reconsideration based on unexpected results from a study of treatment of benign prostatic hyperplasia with dutasteride

2020 ◽  
pp. 205141582092630
Author(s):  
Masanori Nukui
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Sex Hormones ◽  
Prostate Volume ◽  
Specific Antigen ◽  
Prostatic Hyperplasia ◽  
Level Of Evidence ◽  
Prostate Hyperplasia ◽  
Natural Decrease ◽  
One Year ◽  
Benign Prostate

Objective: This study aimed to evaluate the effect of dutasteride treatment of benign prostatic hyperplasia on serum steroidal sex hormones and prostate volume (PV). Methods: Thirty patients with benign prostate hyperplasia treated with dutasteride for one year were assessed for changes in PV and serum sex hormones (testosterone (T), dihydotestosterone (DHT), estradiol (E2) and dehydroepiandrosterone sulphate (DHEAS)). PV was measured by ultrasonography. A paired or unpaired t-test and Pearson’s correlation coefficient test were used for statistical analysis. Results: DHT and DHEAS decreased by 38.5% and 20.3%, respectively. On the contrary, T and E2 increased by 34.3% and 9.4%, respectively. PV and prostate-specific antigen decreased by 17.7% and 63.4%, respectively. The rate of decrease of DHT had a negative correlation with PV, and the rate of decrease of DHEAS had positive correlation with PV. Conclusion: DHT did not decrease as expected (previous studies showed a decrease of approximately 90%). However, DHEAS decreased more than a natural decrease. It is possible that the conversion from DHEAS to DHT, via the conversion to T, in the prostate was accelerated by the decrease of DHT, especially in larger prostates. However, this discrepancy cannot be full explained by the conversion from DHEAS to DHT, as mentioned above. Level of evidence: Level 2c

scholarly journals Picture Of Age Factors And Sexual Activity With The Incidence Of Benign Prostate Hyperplasia

2017 ◽  
Vol 1 (2) ◽  
pp. 16-25
Author(s):  
Hamdana ◽  
Fatmawati
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Sexual Activity ◽  
Sampling Method ◽  
Age Factors ◽  
Prostatic Hyperplasia ◽  
Benign Disease ◽  
Prostate Hyperplasia ◽  
Descriptive Approach ◽  
The Right ◽  
Benign Prostate

In Indonesia Prostate Hyperplasia Benigna Based on the autopsy rate of microscopic changes at the age of 30-40 years. When microscopic changes develop, anatomic pathologic changes occur in men aged 50 years, the incidence rate is around 50%. 80 years old around 80% and 90 years old 100%. Prevalence increases because of an increase in life expectancy. The results of a survey conducted on Benigna Prostate Hyperplasia patients at H. Andi Sulthan Daeng Radja Hospital in Bulukumba District, patients with Benigna Prostate Hyperplasia have an average age of> 50 years as many as 30 people. This study aims to determine the description of age and sexual activity with the incidence of hyperplasia prostate benign disease in H. Andi Sulthan Daeng Radja District Hospital. This study uses a descriptive approach with a population of 30 and is sampled. Sampling using the Total Sampling method. The results of research on the incidence of prostate hyperplasia benign disease mostly occur with age and partial sexual activity who experience benign prostatic hyperplasia more normal sexual activity 1-2 times/weeks and only a few are abnormal sex frequency. The conclusion of the study is the age category of the initial elderly as many as 7 people (23.3%), the final elderly as many as 8 people (26.7%). While the age of seniors as many as 15 people (50%) the category of normal sex frequency <3 times/week as many as 16 respondents (53.3%) and as many as 14 respondents (46.7%) who do sexual frequency> 3 times a week. The suggestion from this research is that it should pay attention to various aspects that can influence the occurrence of hyperplasia prostate benign in patients so that its incidence can be prevented and can provide good service, as well as the right action for sufferers of benign prostatic hyperplasia.

scholarly journals Surgical treatment of benign prostatic hyperplasia: the past and the present

2019 ◽  
Vol 9 (1) ◽  
pp. 47-56
Author(s):  
Ali T. Mustafaev ◽  
Pavel S. Kyzlasov ◽  
Maksim P. Dianov ◽  
Aleksej G. Martov ◽  
Dmitrij V. Ergakov ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Benign Prostatic Hyperplasia ◽  
Minimally Invasive ◽  
Prostatic Hyperplasia ◽  
Surgical Interventions ◽  
The Past ◽  
Minimally Invasive Surgical ◽  
History Of

The article reflects the history of treatment of benign prostatic hyperplasia from the age of antiquity to the present day. Approaches to surgical treatment have undergone significant changes in the last century – from traumatic open operations to minimally invasive surgical interventions using innovative endoscopic technologies. However, some issues in the treatment of benign prostatic hyperplasia remain unresolved which leads to the search for new, safer and more effective methods of surgical treatment of the disease.

The history of the background and modification of surgical methods for treatment of benign prostate hyperplasia

2021 ◽  
pp. 61-69
Author(s):  
Mark Albertovich Volodin ◽  
Maya Andreevna Kuzmina ◽  
Daria Dmitrievna Vasina ◽  
Evgeny Nikolaevich Bolgov ◽  
Vladimir Aleksandrovich Perchatkin
Keyword(s):  
Benign Prostatic Hyperplasia ◽  
Surgical Techniques ◽  
Prostatic Hyperplasia ◽  
Prostate Hyperplasia ◽  
Surgical Interventions ◽  
Literary Sources ◽  
Surgical Methods ◽  
History Of ◽  
Methods Of Treatment

The article presented an overview of literary sources, which include a description of various surgical techniques for the treatment of benign prostatic hyperplasia in different historical periods. The assessment of the disadvantages and advantages of various surgical methods for the treatment of benign prostatic hyperplasia has been made. Modification and improvement of surgical interventions, changes in methods and approaches to surgical treatment of benign prostatic hyperplasia made the surgeon’s work more accessible and of high quality. The development of surgical methods of treatment has made it possible to increase the efficiency of surgical interventions, which, in turn, has a positive effect on the quality of life of urological patients.

scholarly journals The Significance of PSA/IGF-1 Ratio in Differentiating Benign Prostate Hyperplasia from Prostate Cancer

2000 ◽  
Vol 16 (3-4) ◽  
pp. 143-146 ◽  
Author(s):  
G. Koliakos ◽  
D. Chatzivasiliou ◽  
Th. Dimopoulos ◽  
V. Trachana ◽  
K. Paschalidou ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Benign Prostatic Hyperplasia ◽  
Roc Analysis ◽  
Benign Prostate Hyperplasia ◽  
Specific Antigen ◽  
Prostatic Hyperplasia ◽  
Prostate Hyperplasia ◽  
Patients With Cancer ◽  
Free Psa ◽  
Benign Prostate

The importance of insulin-like growth factor 1 (IGF-1) in human serum for the early diagnosis of prostate cancer is controversial. The IGF-1/PSA ratio may improve the performance of prostate specific antigen (PSA) as a prostate cancer marker. IGF-1, along with PSA and free PSA concentration, was measured in the serum of 34 patients with prostate cancer and in 131 patients with benign prostatic hyperplasia (BPH). Although IGF-1 concentration did not significantly differ between the groups, PSA/IGF-1 ratio could clearly distinguish the two groups. In patients with cancer but not in patients with BPH, IGF-1 concentration correlated with PSA and free PSA. The values of PSA and free PSA correlated with each other for both groups. Receivers Operating Curve (ROC) analysis indicated a better sensitivity to specificity ratio for PSA/IGF-1 than for PSA or Free/Total (F/T) PSA.

Sign in / Sign up

Export Citation Format

Share Document